Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Remote Assessments Need Clearer Closeout Process, More Transparency, Experts Argue
Dec 16 2025
•
By
Sue Sutter
The details about RRA frequency and purpose are opaque.
(Shutterstock)
More from Manufacturing
More from FDLI